NDC 0378-1905-05 - Roflumilast
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0378-1905
- Requested NDC
- 0378-1905-05
- Package NDCs from labels
- 0378-1905-93, 0378-1905-77, 0378-1905-05
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Effective date
- 2021-01-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Roflumilast - Mylan Pharmaceuticals Inc. | Mylan Pharmaceuticals Inc. | 2021-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0378-1905-77 | EA - Each | 0378-1905 | c9bf27c8-61fb-42c3-a367-f16da4ffe44e | 1 | 2022-11-07 |
| 0378-1905-93 | EA - Each | 0378-1905 | 3b8d2047-1a3a-4f93-ad92-1a9846e1b21b | 1 | 2022-11-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Roflumilast | ROFLUMILAST | Zydus Lifesciences Limited | e87287bd-eae3-46c3-9072-04800aeabf40 | 2024-08-12 | 0P6C6ZOP5U | |
| Pure Cornstarch Baby | CORN STARCH | Walgreen Company | d0e9bd13-b568-4f7e-b036-8d23e71ad8bf | 2024-03-25 | Warnings | O8232NY3SJ |
| Roflumilast | ROFLUMILAST | Camber Pharmaceuticals, Inc. | f25a0230-3cf6-4366-bebe-0ea5ff8de5ab | 2023-04-28 | Warnings, Adverse reactions | 0P6C6ZOP5U |
| ROFLUMILAST | ROFLUMILAST | Solco Healthcare US, LLC. | 4251c764-7224-4f94-9de7-b6c76cb1f5cd | 2022-05-10 | Warnings, Adverse reactions | 0P6C6ZOP5U |
| 1bf78a47-beb6-452c-9010-9eebd6acbf0b | 0a917c07-edeb-44f0-a26c-8161166dc30b | 2021-01-13 | Warnings, Adverse reactions | 1bf78a47-beb6-452c-9010-9eebd6acbf0b 0a917c07-edeb-44f0-a26c-8161166dc30b | ||
| Daliresp | ROFLUMILAST | AstraZeneca Pharmaceuticals LP | c9a1d0a8-581f-4f91-a2b8-f419192d0ebf | 2020-03-12 | Warnings, Adverse reactions | 0P6C6ZOP5U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.